OXFORD, United Kingdom - Oxford-based medical equipment manufacturing company OrganOx has announced the successful completion of its latest funding round, raising an impressive $32,715,000. The funding was led by LAUXERA CAPITAL PARTNERS, a renowned venture capital firm specializing in supporting groundbreaking innovations in the medical industry.

OrganOx, founded by Constantin Coussios, a visionary entrepreneur, and Professor Peter Friend, a pioneer in organ preservation and maintenance, has been at the forefront of transforming transplantation with their revolutionary product, the OrganOx metra®. This transportable, automated ex vivo liver perfusion device is set to redefine the landscape of organ transplantation.

The core technology that powers the OrganOx metra® has been meticulously developed over 15 years, with Professors Peter Friend and Constantin Coussios leading the charge in advancing organ preservation and maintenance, first at the University of Cambridge and subsequently at the University of Oxford.

As a spin-out from the University of Oxford, OrganOx Limited was established in April 2008, with a mission to bridge the gap between conventional cold preservation and warm preservation in organ transplantation. The OrganOx metra® represents a significant leap forward in this field, offering a solution that goes beyond the limitations of traditional preservation methods.

"We are thrilled to have secured this funding led by LAUXERA CAPITAL PARTNERS, as it will enable us to accelerate the commercialization and global distribution of the OrganOx metra®," said Constantin Coussios, Founder of OrganOx. "Our mission, 'Living Organs For Life,' drives us to make a meaningful impact on the lives of patients awaiting organ transplantation. With this investment, we are one step closer to fulfilling that vision and transforming the landscape of transplantation forever."